Blocking α4β7 Integrin Through Vedolizumab: Necessary but not Sufficient?

被引：7
作者：
Dreesen, Erwin [1 ]
Gils, Ann [1 ]
机构：
[1] Katholieke Univ Leuven, Lab Therapeut & Diagnost Antibodies, Dept Pharmaceut & Pharmacol Sci, O&N 2 Herestr 49,Box 820, B-3000 Leuven, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷 / 08期
关键词：
CROHNS-DISEASE; MAINTENANCE THERAPY; ULCERATIVE-COLITIS; INDUCTION;
D O I：
10.1093/ecco-jcc/jjx033
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：903 / 904
页数：2
相关论文
共 11 条
[1]   Effect of Tumor Necrosis Factor-α Blockade on Mucosal Addressin Cell-adhesion Molecule-1 in Crohn's Disease [J].
Biancheri, Paolo ;
Di Sabatino, Antonio ;
Rovedatti, Laura ;
Giuffrida, Paolo ;
Calarota, Sandra A. ;
Vetrano, Stefania ;
Vidali, Francesca ;
Pasini, Alessandra ;
Danese, Silvio ;
Corazza, Gino R. ;
MacDonald, Thomas T. .
INFLAMMATORY BOWEL DISEASES, 2013, 19 (02) :259-264
[2]  
Dreesen E, 2016, CURR DRUG TARGETS
[3]   Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis [J].
Feagan, Brian G. ;
Rutgeerts, Paul ;
Sands, Bruce E. ;
Hanauer, Stephen ;
Colombel, Jean-Frederic ;
Sandborn, William J. ;
Van Assche, Gert ;
Axler, Jeffrey ;
Kim, Hyo-Jong ;
Danese, Silvio ;
Fox, Irving ;
Milch, Catherine ;
Sankoh, Serap ;
Wyant, Tim ;
Xu, Jing ;
Parikh, Asit .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08) :699-710
[4]   Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo [J].
Fischer, Anika ;
Zundler, Sebastian ;
Atreya, Raja ;
Rath, Timo ;
Voskens, Caroline ;
Hirschmann, Simon ;
Lopez-Posadas, Rocio ;
Watson, Alastair ;
Becker, Christoph ;
Schuler, Gerold ;
Neufert, Clemens ;
Atreya, Imke ;
Neurath, Markus F. .
GUT, 2016, 65 (10) :1642-U290
[5]   Compartment-specific immunity in the human gut: properties and functions of dendritic cells in the colon versus the ileum [J].
Mann, Elizabeth R. ;
Bernardo, David ;
English, Nicholas R. ;
Landy, Jon ;
Al-Hassi, Hafid O. ;
Peake, Simon T. C. ;
Man, Ripple ;
Elliott, Timothy R. ;
Spranger, Henning ;
Lee, Gui Han ;
Parian, Alyssa ;
Brant, Steven R. ;
Lazarev, Mark ;
Hart, Ailsa L. ;
Li, Xuhang ;
Knight, Stella C. .
GUT, 2016, 65 (02) :256-270
[6]   Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease [J].
Rosario, M. ;
Dirks, N. L. ;
Gastonguay, M. R. ;
Fasanmade, A. A. ;
Wyant, T. ;
Parikh, A. ;
Sandborn, W. J. ;
Feagan, B. G. ;
Reinisch, W. ;
Fox, I. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (02) :188-202
[7]   Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease [J].
Rosario, Maria ;
French, Jonathan L. ;
Dirks, Nathanael L. ;
Sankoh, Serap ;
Parikh, Asit ;
Yang, Huyuan ;
Danese, Silvio ;
Colombel, Jean-Frederic ;
Smyth, Michael ;
Sandborn, William J. ;
Feagan, Brian G. ;
Reinisch, Walter ;
Sands, Bruce E. ;
Sans, Miguel ;
Fox, Irving .
JOURNAL OF CROHNS & COLITIS, 2017, 11 (08) :921-929
[8]   Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease [J].
Sandborn, William J. ;
Feagan, Brian G. ;
Rutgeerts, Paul ;
Hanauer, Stephen ;
Colombel, Jean-Frederic ;
Sands, Bruce E. ;
Lukas, Milan ;
Fedorak, Richard N. ;
Lee, Scott ;
Bressler, Brian ;
Fox, Irving ;
Rosario, Maria ;
Sankoh, Serap ;
Xu, Jing ;
Stephens, Kristin ;
Milch, Catherine ;
Parikh, Asit .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08) :711-721
[9]   Effects of Vedolizumab Induction Therapy for Patients With Crohn's Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed [J].
Sands, Bruce E. ;
Feagan, Brian G. ;
Rutgeerts, Paul ;
Colombel, Jean-Frederic ;
Sandborn, William J. ;
Sy, Richmond ;
D'Haens, Geert ;
Ben-Horin, Shomron ;
Xu, Jing ;
Rosario, Maria ;
Fox, Irving ;
Parikh, Asit ;
Milch, Catherine ;
Hanauer, Stephen .
GASTROENTEROLOGY, 2014, 147 (03) :618-+
[10]   In vitro assessment of the effects of vedolizumab binding on peripheral blood lymphocytes [J].
Wyant, Timothy ;
Yang, Lili ;
Fedyk, Eric .
MABS, 2013, 5 (06) :842-850
12